No matches

16 search results for: remission

Pulmonology

ADVENT On Air | Disease Modification in Severe Asthma: Framework, Assessment, and Clinical Impact

21 min

Podcast

Join Professors Brusselle and Backer as they discuss the concept of disease modification in asthma.

Dermatology

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis

5 min

Infographic

An infographic to explore the the key roles of CCL17 (TARC) in atopic dermatitis.

Dermatology

ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis

20 min

Podcast

Prof. Thomas Bieber explores early intervention and disease modification in atopic dermatitis.

Rhinology

How do You Define Active Disease (CRSwNP) When Looking at the Nose With an Endoscope?

2 min

expert video

In this video clip from the EAACI 2024 symposium, Dr. Mullol discusses the challenge of defining active nasal disease using an endoscope.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: PanamaChange country/region